Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PS-341 Followed by Radical Prostatectomy for Prostate Adenocarcinoma
NCT00425503Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Dec 2001
- Primary completion
- Nov 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in prostate adenocarcinoma, sponsored by Baylor College of Medicine. Started Dec 2001; status: completed.
02
Drugs
bortezomib
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT00425503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425503.